|
Volumn 14, Issue 4, 2000, Pages 188-192
|
New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women
|
Author keywords
Antibody activities; ELISA; HIV1 gp160
|
Indexed keywords
GLYCOPROTEIN GP 160;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN G ANTIBODY;
ANALYTIC METHOD;
ANTIBODY BLOOD LEVEL;
ANTIBODY DETECTION;
ANTIBODY TITER;
ANTIGEN BINDING;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
DIAGNOSTIC ACCURACY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAVIMETRY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTERMETHOD COMPARISON;
QUANTITATIVE ASSAY;
REPRODUCIBILITY;
SALIVA ANALYSIS;
VAGINA SECRETION;
VALIDATION PROCESS;
|
EID: 0033940997
PISSN: 08878013
EISSN: None
Source Type: Journal
DOI: 10.1002/1098-2825(2000)14:4<188::AID-JCLA8>3.3.CO;2-V Document Type: Article |
Times cited : (2)
|
References (12)
|